DOAJ Open Access 2017

Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

Nicola Gökbuget Gerhard Zugmaier Matthias Klinger Peter Kufer Matthias Stelljes +9 lainnya

Lihat Sumber DOI

Topik & Kata Kunci

Diseases of the blood and blood-forming organs

Penulis (14)

Nicola Gökbuget

Gerhard Zugmaier

Matthias Klinger

Peter Kufer

Matthias Stelljes

Andreas Viardot

Heinz A. Horst

Svenja Neumann

Monika Brüggemann

Oliver G. Ottmann

Thomas Burmeister

Dorothea Wessiepe

Max S. Topp

Ralf Bargou

Format Sitasi

APA MLA BibTeX

Gökbuget, N., Zugmaier, G., Klinger, M., Kufer, P., Stelljes, M., Viardot, A. et al. (2017). Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia. https://doi.org/10.3324/haematol.2016.153957

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.3324/haematol.2016.153957

Informasi Jurnal

Tahun Terbit: 2017
Sumber Database: DOAJ
DOI: 10.3324/haematol.2016.153957
Akses: Open Access ✓